Growth Metrics

Merck (MRK) Accounts Payables (2016 - 2026)

Merck has reported Accounts Payables over the past 18 years, most recently at $3.9 billion for Q1 2026.

  • Quarterly Accounts Payables rose 2.09% to $3.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.9 billion through Mar 2026, up 2.09% year-over-year, with the annual reading at $4.4 billion for FY2025, 7.97% up from the prior year.
  • Accounts Payables was $3.9 billion for Q1 2026 at Merck, down from $4.4 billion in the prior quarter.
  • Over five years, Accounts Payables peaked at $4.4 billion in Q4 2025 and troughed at $3.4 billion in Q3 2022.
  • The 5-year median for Accounts Payables is $3.7 billion (2022), against an average of $3.8 billion.
  • Year-over-year, Accounts Payables fell 10.65% in 2022 and then rose 15.64% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $4.3 billion in 2022, then decreased by 8.02% to $3.9 billion in 2023, then grew by 4.0% to $4.1 billion in 2024, then rose by 7.97% to $4.4 billion in 2025, then fell by 12.28% to $3.9 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Accounts Payables are $3.9 billion (Q1 2026), $4.4 billion (Q4 2025), and $4.1 billion (Q3 2025).